CrossRefPubMed 5. Parikh P, Malhotra H, Jelic S, Group. EGW: Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008, 19: 27–28.CrossRef 6. Sheehe PR: Combination of log relative risk in retrospective studies of disease. Am J Public Health Nations Health 1966, 56: 1745–1750.CrossRefPubMed 7. Fleiss JL: The statistical basis of meta-analysis. Stat Methods Med Res 1993, 2: 121–145.CrossRefPubMed 8. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21: 1539–1558.CrossRefPubMed 9. Bai GD, Liang ZP, Huang JP, Hou EC: A clinical analysis on the therapeutic effect of integrative medicine therapy on primary middle and advanced stage
cancer treatment. Jiangsu GSK2118436 order Journal of Traditional AZ 628 research buy Chinese Medicine 2008, 40 (8) : 27–29. 10. Cao GW, Wang XC, Zhang FL, Ning HF, Sun YQ, Yan LF: Clinical Observation of Ganfukang capsule combined with TACE in primary liver cancer treatment. Shandong Medical Journal 2005, 45 (2) : 13–14. 11. Cao MR, Tang HL: Clinical study of Ai Di injection combined with transcatheter arterial chemoembolization in treatment of middle and advanced stage liver cancer. Chinese Journal of Integrative Medicine 2003, 23 (9) : 713–714. 12. Chen C, Zhou JG, Huang HC, Ruan SH, Zhang QS: Hepatic artery lipiodol infusion chemotherapy combined with Pei Yuan Gu Ben Kang Ai capsule Crizotinib chemical structure in the treatment of 42 cases Bupivacaine of mid- and late-stage
hepatocellular carcinoma. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases 2001, 11 (3) : 183–184. 13. Feng J: TCM combined with interventional therapy in 35 cases of primary liver cancer. Journal of Guangxi Traditional Chinese Medical University 2002, 151 (13) : 51–52. 14. Guo TS, Huang FX, Cao XL: Jew Ear Parasitized Granula combined with TACE on Hepatocellular Carcinoma. Chinese Journals
of Practical Medicine 2005, 21 (16) : 1846–1847. 15. Li DJ, Xu X, Bao D, Xue F, Dai DL: Effects of kanglaite capsules combined with transcatheter arterial chemoembolization (TACE) on patients with mid or late-stage primary hepatocellular carcinoma (HCC). Chinese-German Journal of Clinical Oncology 2009, 8 (2) : 65–68.CrossRef 16. Li M: Chinese herbal compound combined with TACE in primary liver cancer treatment. Clinical Research 2007, 3 (31) : 40–41. 17. Li Q, Sun BM, Peng YH, Fan ZZ, Jue S: Clinical Study on the Treatment of Primary Liver Cancer by Cinobufotain Combined with Transcatheter Arterial Chemoembolization. ACTA UNIVERSITATIS TRADITIONIS MEDICALIS SINENSIS PHARMACOLOGIAEQUE SHANGHAI 2008, 22 (2) : 32–34. 18. Li QM, Zhao YL: Qining injection combined with Interventional therapy in liver cancer treatment. Journal of Cancer Control and Treatment 2003, 16 (3) : 160–161. 19. Li RP: Clinical Observation of Ai Di Injection combined with transarterial chemembolization in primary liver treatment. Central Plains Medical Journal 2005, 32 (24) : 69. 20.